| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |